Engineering genomics. RNA antagonists--a new class of antisense drugs.
Orum
Henrik
H
CSO Santaris Pharma A/S,, Hørsholm, Denmark. hoe@santaris.com
D000818:Animals; D002986:Clinical Trials as Topic; D015195:Drug Design; D020868:Gene Silencing; D018390:Gene Targeting / Q000379:methods*; D005818:Genetic Engineering / Q000379:methods*; D015316:Genetic Therapy / Q000379:methods*; D006801:Humans; D010597:Pharmacogenetics / Q000379:methods; D034622:RNA Interference; D016372:RNA, Antisense / Q000627:therapeutic use*
D016372:RNA, Antisense